To investigate the role of Lactobacillus reuteri in the treatment of ulcerative colitis with Luohuazizhu Granules.
Twelve BALB/c mice were selected and randomly divided into the normal group and the Luohuazizhu granules group. After intragastric administration for 7 days, the mice were euthanized after the last administration. 16S rDNA sequencing technology was used to screen out the bacterial species that were enriched in the intestines after the intervention with Luohuazizhu granules. Forty mice were randomly divided into the normal group, the model group, the Luohuazizhu granules. group, the Lactobacillus reuteri group, and the combined treatment group(Luohuazizhu granules+Lactobacillus reuteri). Mice were administered intragastrically the antibiotic solution 5 days in advance for intestinal flora clearance. The Lactobacillus reuteri group and combined group were colonized by single bacteria, and the pharmacodynamics of acute ulcerative colitis was studied after successful colonization. The targeted metabolomics and flow cytometry techniques were employed to analyze the bile acid metabolism and immune cell balance in mice.
Compared with the control group, the content of Lactobacillus reuteri in the feces of mice treated with Luohuazizhu granules was showed an increasing trend. Compared to the model group, both Luohuazizhu granules group and Lactobacillus reuteri group ameliorated colitis symptoms in mice, with a . decrease in the disease activity index(P<0.05), a reduction in the degree of colon shortening and histopathological score, but not significantly. After colonization with Lactobacillus reuteri, compared with the model group, both the Luohuazizhu granules and the combined group significantly improved the symptoms of ulcerative colitis in mice(P<0.01), and the bile acid metabolism disorder and immune cells imbalance of mice were also significantly ameliorated(P<0.01).
Lactobacillus reuteri synergistically promotes the therapeutic effect of Luohuazizhu granules, providing a novel strategy for the treatment of ulcerative colitis.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |